Osaic Holdings’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Osaic Holdings’s Portfolio CYAD Stock Details CYAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,500	Closed	-$2K	–	7598
2022 Q3	$2K	Hold	1,500	–	–	﹤0.01%	6896
2022 Q2	$3K	Hold	1,500	–	–	﹤0.01%	6805
2022 Q1	$777K	Hold	1,500	–	–	﹤0.01%	2806
2021 Q4	$6K	Sell	1,500 -380	-20%	-$1.6K	﹤0.01%	6586
2021 Q3	$8K	Buy	+1,880	New	+$8.22K	﹤0.01%	6356

Other funds holding CYAD

FIG

Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Osaic Holdings's CYAD Position: Q4 2022 in Review

Osaic Holdings sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q4 2022, closing a stake of 1,500 shares — an estimated $2K sold.

Osaic Holdings first reported a position in CYAD in Q3 2021 and held it in 5 quarters. The position peaked at $777K in Q1 2022. 8 funds tracked by Wall St. Rank hold CYAD as of Q4 2022.

Osaic Holdings reported no remaining Celyad Oncology SA American Depositary Shares position as of Q4 2022 after selling out during the quarter.
Osaic Holdings sold 1,500 Celyad Oncology SA American Depositary Shares shares in Q4 2022, an estimated $2K.
Osaic Holdings first reported a position in Celyad Oncology SA American Depositary Shares in Q3 2021 and held it in 5 quarters.
Osaic Holdings's Celyad Oncology SA American Depositary Shares position peaked at $777K in Q1 2022.
8 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q4 2022.

Based on Osaic Holdings's 13F filing for Q4 2022, filed 10 Feb 2023.